These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 26245377)

  • 1. Propagation of conformational changes during μ-opioid receptor activation.
    Sounier R; Mas C; Steyaert J; Laeremans T; Manglik A; Huang W; Kobilka BK; Déméné H; Granier S
    Nature; 2015 Aug; 524(7565):375-8. PubMed ID: 26245377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural insights into µ-opioid receptor activation.
    Huang W; Manglik A; Venkatakrishnan AJ; Laeremans T; Feinberg EN; Sanborn AL; Kato HE; Livingston KE; Thorsen TS; Kling RC; Granier S; Gmeiner P; Husbands SM; Traynor JR; Weis WI; Steyaert J; Dror RO; Kobilka BK
    Nature; 2015 Aug; 524(7565):315-21. PubMed ID: 26245379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand based conformational space studies of the μ-opioid receptor.
    Sena DM; Cong X; Giorgetti A
    Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129838. PubMed ID: 33373630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the µ-opioid receptor-G
    Koehl A; Hu H; Maeda S; Zhang Y; Qu Q; Paggi JM; Latorraca NR; Hilger D; Dawson R; Matile H; Schertler GFX; Granier S; Weis WI; Dror RO; Manglik A; Skiniotis G; Kobilka BK
    Nature; 2018 Jun; 558(7711):547-552. PubMed ID: 29899455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric coupling from G protein to the agonist-binding pocket in GPCRs.
    DeVree BT; Mahoney JP; Vélez-Ruiz GA; Rasmussen SG; Kuszak AJ; Edwald E; Fung JJ; Manglik A; Masureel M; Du Y; Matt RA; Pardon E; Steyaert J; Kobilka BK; Sunahara RK
    Nature; 2016 Jul; 535(7610):182-6. PubMed ID: 27362234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the β2 Adrenergic Receptor.
    Chen Y; Fleetwood O; Pérez-Conesa S; Delemotte L
    J Chem Inf Model; 2021 Dec; 61(12):6024-6037. PubMed ID: 34780174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of β-arrestin recruitment by the μ-opioid G protein-coupled receptor.
    Mafi A; Kim SK; Goddard WA
    Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16346-16355. PubMed ID: 32601232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation.
    Staus DP; Strachan RT; Manglik A; Pani B; Kahsai AW; Kim TH; Wingler LM; Ahn S; Chatterjee A; Masoudi A; Kruse AC; Pardon E; Steyaert J; Weis WI; Prosser RS; Kobilka BK; Costa T; Lefkowitz RJ
    Nature; 2016 Jul; 535(7612):448-52. PubMed ID: 27409812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist.
    Neilan CL; Husbands SM; Breeden S; Ko MC; Aceto MD; Lewis JW; Woods JH; Traynor JR
    Eur J Pharmacol; 2004 Sep; 499(1-2):107-16. PubMed ID: 15363957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational insights into the G-protein-biased activation and inactivation mechanisms of the μ opioid receptor.
    Cheng JX; Cheng T; Li WH; Liu GX; Zhu WL; Tang Y
    Acta Pharmacol Sin; 2018 Jan; 39(1):154-164. PubMed ID: 29188799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-stabilized conformational states of human beta(2) adrenergic receptor: insight into G-protein-coupled receptor activation.
    Bhattacharya S; Hall SE; Li H; Vaidehi N
    Biophys J; 2008 Mar; 94(6):2027-42. PubMed ID: 18065472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Backbone NMR reveals allosteric signal transduction networks in the β1-adrenergic receptor.
    Isogai S; Deupi X; Opitz C; Heydenreich FM; Tsai CJ; Brueckner F; Schertler GF; Veprintsev DB; Grzesiek S
    Nature; 2016 Feb; 530(7589):237-41. PubMed ID: 26840483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of allosteric coupling in human β2-adrenergic receptor in the presence of intracellular loop 3.
    Ozgur C; Doruker P; Akten ED
    BMC Struct Biol; 2016 Jul; 16(1):9. PubMed ID: 27368374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the µ-opioid receptor bound to a morphinan antagonist.
    Manglik A; Kruse AC; Kobilka TS; Thian FS; Mathiesen JM; Sunahara RK; Pardo L; Weis WI; Kobilka BK; Granier S
    Nature; 2012 Mar; 485(7398):321-6. PubMed ID: 22437502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor.
    Bokoch MP; Zou Y; Rasmussen SG; Liu CW; Nygaard R; Rosenbaum DM; Fung JJ; Choi HJ; Thian FS; Kobilka TS; Puglisi JD; Weis WI; Pardo L; Prosser RS; Mueller L; Kobilka BK
    Nature; 2010 Jan; 463(7277):108-12. PubMed ID: 20054398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The local environment at the cytoplasmic end of TM6 of the mu opioid receptor differs from those of rhodopsin and monoamine receptors: introduction of an ionic lock between the cytoplasmic ends of helices 3 and 6 by a L6.30(275)E mutation inactivates the mu opioid receptor and reduces the constitutive activity of its T6.34(279)K mutant.
    Huang P; Visiers I; Weinstein H; Liu-Chen LY
    Biochemistry; 2002 Oct; 41(40):11972-80. PubMed ID: 12356297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the molecular basis of agonist/antagonist mechanism of human mu opioid receptor through gaussian accelerated molecular dynamics method.
    Wang YT; Chan YH
    Sci Rep; 2017 Aug; 7(1):7828. PubMed ID: 28798303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying conformational changes in GPCRs: glimpse of a common functional mechanism.
    Dalton JA; Lans I; Giraldo J
    BMC Bioinformatics; 2015 Apr; 16(1):124. PubMed ID: 25902715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex of an active mu-opioid receptor with a cyclic peptide agonist modeled from experimental constraints.
    Fowler CB; Pogozheva ID; Lomize AL; LeVine H; Mosberg HI
    Biochemistry; 2004 Dec; 43(50):15796-810. PubMed ID: 15595835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.